Abstract
A group of 690 patients (337 males and 353 females) on long-term acenocoumarol therapy was studied. 62.8% of the values of the prothrombin ratio were within the chosen therapeutic range (1.8 to 2.7), 21.9% were below 1.8 and 15.3% were above 2.7. The daily maintenance dose, expressed on a weight basis, was found to significantly decrease with increasing age. The daily maintenance dose taken by females was significantly higher than the dose taken by males (P less than 0.05); the differences between males and females were maximal among patients aged between 21 and 50 years, and disappeared at older ages. Two hundred and twenty-eight haemorrhagic episodes in 160 patients were recorded during a total of 7797 months of follow-up. No lethal haemorrhages were observed. The overall incidence of bleeding episodes among females (3.6%) was higher than among males (2.2%) (P less than 0.001), even if menorrhagia was excluded (P less than 0.01).
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Coope J., Thomson J. M., Poller L. Effects of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting. Br Med J. 1975 Oct 18;4(5989):139–143. doi: 10.1136/bmj.4.5989.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eccles J. T. Control of warfarin therapy in the elderly. Age Ageing. 1975 Aug;4(3):161–165. doi: 10.1093/ageing/4.3.161. [DOI] [PubMed] [Google Scholar]
- Husted S., Andreasen F. Problems encountered in long-term treatment with anticoagulants. Acta Med Scand. 1976;200(5):379–384. doi: 10.1111/j.0954-6820.1976.tb08250.x. [DOI] [PubMed] [Google Scholar]
- Husted S., Andreasen F. The influence of age on the response to anticoagulants. Br J Clin Pharmacol. 1977 Oct;4(5):559–565. doi: 10.1111/j.1365-2125.1977.tb00786.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim H. C., Kemmann E., Shelden R. M., Saidi P. Response of blood coagulation parameters to elevated endogenous 17 beta-estradiol levels induced by human menopausal gonadotropins. Am J Obstet Gynecol. 1981 Aug 1;140(7):807–810. doi: 10.1016/0002-9378(81)90744-4. [DOI] [PubMed] [Google Scholar]
- O'Malley K., Stevenson I. H., Ward C. A., Wood A. J., Crooks J. Determinants of anticoagulant control in patients receiving warfarin. Br J Clin Pharmacol. 1977 Jun;4(3):309–314. doi: 10.1111/j.1365-2125.1977.tb00718.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- POLLARD J. W., HAMILTON M. J., CHRISTENSEN N. A., ACHOR R. W. Problems associated with long-term anticoagulant therapy. Observations in 139 cases. Circulation. 1962 Feb;25:311–317. doi: 10.1161/01.cir.25.2.311. [DOI] [PubMed] [Google Scholar]
- Poller L. Oral contraceptives, blood clotting and thrombosis. Br Med Bull. 1978 May;34(2):151–156. doi: 10.1093/oxfordjournals.bmb.a071485. [DOI] [PubMed] [Google Scholar]
- Routledge P. A., Chapman P. H., Davies D. M., Rawlins M. D. Factors affecting warfarin requirements. A prospective population study. Eur J Clin Pharmacol. 1979 Jun 12;15(5):319–322. doi: 10.1007/BF00558434. [DOI] [PubMed] [Google Scholar]
- Shepherd A. M., Hewick D. S., Moreland T. A., Stevenson I. H. Age as a determinant of sensitivity to warfarin. Br J Clin Pharmacol. 1977 Jun;4(3):315–320. doi: 10.1111/j.1365-2125.1977.tb00719.x. [DOI] [PMC free article] [PubMed] [Google Scholar]